| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.6 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | isoevodiamine | CTRPv2 | pan-cancer | AAC | 0.016 | 0.6 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.032 | 0.7 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |